Mircera
Facts from the Community
From the BioVenturist base
Target/Biomolecule of Interest:
Indication or disease:
| Disease | Phase of development |
|---|---|
Delivery Technology:
Technology involved:
Developed by:
Brand Names:
- Mircera
We can tell you that Mircera is a…
If you know more about Mircera, you can add more facts here »
Similar topics in Freebase
-
MetMAb
-
PEGASYS
Pegylated interferon alfa-2a (40 kDa; commercial name Pegasys) is an antiviral drug discovered at the pharmaceutical company F. Hoffmann-La Roche; it has a dual mode of action - both antiviral and on the immune system. The additon of polyethylene glycol to the interferon, through a process known as... -
Daclizumab
Daclizumab (trade name Zenapax) was a therapeutic humanized monoclonal antibody to the alpha subunit of the IL-2 receptor of T cells. It was used to prevent rejection in organ transplantation, especially in kidney transplants. In April 2008, its manufacturer submitted an application to have its... -
GEN - Anti-IL13
-
Darbepoetin alfa
Darbepoetin alfa (rINN) (pronounced /dɑrbəˈpɔɪtɨn/) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the... -
Pegfilgrastim
Pegfilgrastim is a immunostimulator which functions as a PEGylated granulocyte colony-stimulating factor. Amgen manufactures pegfilgrastim under the brand name Neulasta.
You can help improve this topic by adding more facts here
